PKD2 and cholangiocarcinoma: Another study using sixty CCA patients (intrahepatic, extrahepatic, and perihilar) has identified lnc-PKD2-2-3 as a candidate lncRNA, and high lnc-PKD2-2-3 expression was correlated with poor survival rates and high TNM stages (51).